An early and stable mouse model of polymyxin-induced acute kidney injury.

IF 2.8 Q2 CRITICAL CARE MEDICINE
Linqiong Liu, Yuxi Liu, Yu Xin, Yanqi Liu, Yan Gao, Kaijiang Yu, Changsong Wang
{"title":"An early and stable mouse model of polymyxin-induced acute kidney injury.","authors":"Linqiong Liu, Yuxi Liu, Yu Xin, Yanqi Liu, Yan Gao, Kaijiang Yu, Changsong Wang","doi":"10.1186/s40635-024-00667-y","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Polymyxins have been revived as a last-line therapeutic option for multi-drug resistant bacteria and continue to account for a significant proportion of global antibiotic usage. However, kidney injury is often a treatment limiting event with kidney failure rates ranging from 5 to 13%. The mechanisms underlying polymyxin-induced nephrotoxicity are currently unclear. Researches of polymyxin-associated acute kidney injury (AKI) models need to be more standardized, which is crucial for obtaining consistent and robust mechanistic results.</p><p><strong>Methods: </strong>In this study, male C57BL/6 mice received different doses of polymyxin B (PB) and polymyxin E (PE, also known as colistin) by different routes once daily (QD), twice daily (BID), and thrice daily (TID) for 3 days. We continuously monitored the glomerular filtration rate (GFR) and the AKI biomarkers, including serum creatinine (Scr), blood urea nitrogen (BUN), neutrophil gelatinase-associated lipocalin (NGAL), and kidney injury molecule-1 (KIM-1). We also performed histopathological examinations to assess the extent of kidney injury.</p><p><strong>Results: </strong>Mice receiving PB (35 mg/kg/day subcutaneously) once daily exhibited a significant decrease in GFR and a notable increase in KIM-1 two hours after the first dose. Changes in GFR and KIM-1 at 24, 48 and 72 h were consistent and demonstrated the occurrence of kidney injury. Histopathological assessments showed a positive correlation between the severity of kidney injury and the changes in GFR and KIM-1 (Spearman's rho = 0.3167, P = 0.0264). The other groups of mice injected with PB and PE did not show significant changes in GFR and AKI biomarkers compared to the control group.</p><p><strong>Conclusion: </strong>The group receiving PB (35 mg/kg/day subcutaneously) once daily consistently developed AKI at 2 h after the first dose. Establishing an early and stable AKI model facilitates researches into the mechanisms of early-stage kidney injury. In addition, our results indicated that PE had less toxicity than PB and mice receiving the same dose of PB in the QD group exhibited more severe kidney injury than the BID and TID groups.</p>","PeriodicalId":13750,"journal":{"name":"Intensive Care Medicine Experimental","volume":"12 1","pages":"88"},"PeriodicalIF":2.8000,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11445218/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Intensive Care Medicine Experimental","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1186/s40635-024-00667-y","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"CRITICAL CARE MEDICINE","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Polymyxins have been revived as a last-line therapeutic option for multi-drug resistant bacteria and continue to account for a significant proportion of global antibiotic usage. However, kidney injury is often a treatment limiting event with kidney failure rates ranging from 5 to 13%. The mechanisms underlying polymyxin-induced nephrotoxicity are currently unclear. Researches of polymyxin-associated acute kidney injury (AKI) models need to be more standardized, which is crucial for obtaining consistent and robust mechanistic results.

Methods: In this study, male C57BL/6 mice received different doses of polymyxin B (PB) and polymyxin E (PE, also known as colistin) by different routes once daily (QD), twice daily (BID), and thrice daily (TID) for 3 days. We continuously monitored the glomerular filtration rate (GFR) and the AKI biomarkers, including serum creatinine (Scr), blood urea nitrogen (BUN), neutrophil gelatinase-associated lipocalin (NGAL), and kidney injury molecule-1 (KIM-1). We also performed histopathological examinations to assess the extent of kidney injury.

Results: Mice receiving PB (35 mg/kg/day subcutaneously) once daily exhibited a significant decrease in GFR and a notable increase in KIM-1 two hours after the first dose. Changes in GFR and KIM-1 at 24, 48 and 72 h were consistent and demonstrated the occurrence of kidney injury. Histopathological assessments showed a positive correlation between the severity of kidney injury and the changes in GFR and KIM-1 (Spearman's rho = 0.3167, P = 0.0264). The other groups of mice injected with PB and PE did not show significant changes in GFR and AKI biomarkers compared to the control group.

Conclusion: The group receiving PB (35 mg/kg/day subcutaneously) once daily consistently developed AKI at 2 h after the first dose. Establishing an early and stable AKI model facilitates researches into the mechanisms of early-stage kidney injury. In addition, our results indicated that PE had less toxicity than PB and mice receiving the same dose of PB in the QD group exhibited more severe kidney injury than the BID and TID groups.

多粘菌素诱发急性肾损伤的早期稳定小鼠模型
背景:多粘菌素作为治疗多重耐药细菌的最后一线疗法已重新焕发生机,并继续在全球抗生素使用量中占据相当大的比例。然而,肾损伤往往是限制治疗的一个因素,肾衰竭率从 5% 到 13% 不等。多粘菌素诱发肾毒性的机制目前尚不清楚。多粘菌素相关急性肾损伤(AKI)模型的研究需要更加标准化,这对于获得一致、可靠的机理研究结果至关重要:在本研究中,雄性 C57BL/6 小鼠通过不同途径接受不同剂量的多粘菌素 B(PB)和多粘菌素 E(PE,又称可乐定),分别为每日一次(QD)、每日两次(BID)和每日三次(TID),共 3 天。我们持续监测肾小球滤过率(GFR)和 AKI 生物标志物,包括血清肌酐(Scr)、血尿素氮(BUN)、中性粒细胞明胶酶相关脂质体(NGAL)和肾损伤分子-1(KIM-1)。我们还进行了组织病理学检查,以评估肾损伤的程度:结果:每天一次皮下注射 PB(35 毫克/千克/天)的小鼠的 GFR 显著下降,KIM-1 在首次用药两小时后明显升高。24、48 和 72 小时后,GFR 和 KIM-1 的变化一致,表明发生了肾损伤。组织病理学评估显示,肾损伤的严重程度与 GFR 和 KIM-1 的变化呈正相关(Spearman's rho = 0.3167,P = 0.0264)。与对照组相比,注射 PB 和 PE 的其他组小鼠的 GFR 和 AKI 生物标志物没有发生显著变化:结论:每天一次皮下注射 PB(35 毫克/千克/天)的小鼠组在首次给药后 2 小时持续出现 AKI。建立早期稳定的 AKI 模型有助于研究早期肾损伤的机制。此外,我们的研究结果表明,PE的毒性低于PB,而接受相同剂量PB的QD组小鼠比BID组和TID组表现出更严重的肾损伤。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Intensive Care Medicine Experimental
Intensive Care Medicine Experimental CRITICAL CARE MEDICINE-
CiteScore
5.10
自引率
2.90%
发文量
48
审稿时长
13 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信